Authors:
Kinsella, TJ
Vielhuber, KA
Kunugi, KA
Schupp, J
Davis, TW
Sands, H
Citation: Tj. Kinsella et al., Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2 '-deoxyribose as a prodrug for 5-iodo-2 '-deoxyuridine radiosensitization in U251 human glioblastoma xenografts, CLIN CANC R, 6(4), 2000, pp. 1468-1475